Literature DB >> 25679954

B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production.

Shaun W Jackson1, Nikita S Kolhatkar2, David J Rawlings3.   

Abstract

A significant proportion of autoimmune-associated genetic variants are expressed in B cells, suggesting that B cells may play multiple roles in autoimmune pathogenesis. In this review, we highlight recent studies demonstrating that even modest alterations in B cell signaling are sufficient to promote autoimmunity. First, we describe several examples of genetic variations promoting B cell-intrinsic initiation of autoimmune germinal centers and autoantibody production. We highlight how dual antigen receptor/toll-like receptor signals greatly facilitate this process and how activated, self-reactive B cells may function as antigen presenting cells, leading to loss of T cell tolerance. Further, we propose that B cell-derived cytokines may initiate and/or sustain autoimmune germinal centers, likely also contributing, in parallel, to programing of self-reactive T cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25679954      PMCID: PMC4397155          DOI: 10.1016/j.coi.2015.01.018

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  66 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Unraveling the genetics of autoimmunity.

Authors:  Lauren A Zenewicz; Clara Abraham; Richard A Flavell; Judy H Cho
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Authors:  Kenneth G C Smith; Menna R Clatworthy
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

4.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.

Authors:  Vesela Gateva; Johanna K Sandling; Geoff Hom; Kimberly E Taylor; Sharon A Chung; Xin Sun; Ward Ortmann; Roman Kosoy; Ricardo C Ferreira; Gunnel Nordmark; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Emily C Baechler; Elizabeth E Brown; Graciela S Alarcón; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Gerald McGwin; John D Reveille; Luis M Vilá; Robert P Kimberly; Susan Manzi; Michelle A Petri; Annette Lee; Peter K Gregersen; Michael F Seldin; Lars Rönnblom; Lindsey A Criswell; Ann-Christine Syvänen; Timothy W Behrens; Robert R Graham
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

5.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.

Authors:  Jian-Wen Han; Hou-Feng Zheng; Yong Cui; Liang-Dan Sun; Dong-Qing Ye; Zhi Hu; Jin-Hua Xu; Zhi-Ming Cai; Wei Huang; Guo-Ping Zhao; Hong-Fu Xie; Hong Fang; Qian-Jin Lu; Jian-Hua Xu; Xiang-Pei Li; Yun-Feng Pan; Dan-Qi Deng; Fan-Qin Zeng; Zhi-Zhong Ye; Xiao-Yan Zhang; Qing-Wen Wang; Fei Hao; Li Ma; Xian-Bo Zuo; Fu-Sheng Zhou; Wen-Hui Du; Yi-Lin Cheng; Jian-Qiang Yang; Song-Ke Shen; Jian Li; Yu-Jun Sheng; Xiao-Xia Zuo; Wei-Fang Zhu; Fei Gao; Pei-Lian Zhang; Qing Guo; Bo Li; Min Gao; Feng-Li Xiao; Cheng Quan; Chi Zhang; Zheng Zhang; Kun-Ju Zhu; Yang Li; Da-Yan Hu; Wen-Sheng Lu; Jian-Lin Huang; Sheng-Xiu Liu; Hui Li; Yun-Qing Ren; Zai-Xing Wang; Chun-Jun Yang; Pei-Guang Wang; Wen-Ming Zhou; Yong-Mei Lv; An-Ping Zhang; Sheng-Quan Zhang; Da Lin; Yi Li; Hui Qi Low; Min Shen; Zhi-Fang Zhai; Ying Wang; Feng-Yu Zhang; Sen Yang; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

6.  Functionally defective germline variants of sialic acid acetylesterase in autoimmunity.

Authors:  Ira Surolia; Stephan P Pirnie; Vasant Chellappa; Kendra N Taylor; Annaiah Cariappa; Jesse Moya; Haoyuan Liu; Daphne W Bell; David R Driscoll; Sven Diederichs; Khaleda Haider; Ilka Netravali; Sheila Le; Roberto Elia; Ethan Dow; Annette Lee; Jan Freudenberg; Philip L De Jager; Yves Chretien; Ajit Varki; Marcy E MacDonald; Tammy Gillis; Timothy W Behrens; Donald Bloch; Deborah Collier; Joshua Korzenik; Daniel K Podolsky; David Hafler; Mandakolathur Murali; Bruce Sands; John H Stone; Peter K Gregersen; Shiv Pillai
Journal:  Nature       Date:  2010-06-16       Impact factor: 49.962

Review 7.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

8.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.

Authors:  Mark D Pescovitz; Carla J Greenbaum; Heidi Krause-Steinrauf; Dorothy J Becker; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Jennifer B Marks; Paula F McGee; Antoinette M Moran; Philip Raskin; Henry Rodriguez; Desmond A Schatz; Diane Wherrett; Darrell M Wilson; John M Lachin; Jay S Skyler
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

Review 9.  Activating systemic autoimmunity: B's, T's, and tolls.

Authors:  Mark J Shlomchik
Journal:  Curr Opin Immunol       Date:  2009-09-30       Impact factor: 7.486

10.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Authors:  Joan T Merrill; C Michael Neuwelt; Daniel J Wallace; Joseph C Shanahan; Kevin M Latinis; James C Oates; Tammy O Utset; Caroline Gordon; David A Isenberg; Hsin-Ju Hsieh; David Zhang; Paul G Brunetta
Journal:  Arthritis Rheum       Date:  2010-01
View more
  27 in total

1.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

Review 2.  The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.

Authors:  Malika Hale; David J Rawlings; Shaun W Jackson
Journal:  Curr Opin Immunol       Date:  2018-11-01       Impact factor: 7.486

Review 3.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Authors:  Adam J Fike; Irina Elcheva; Ziaur S M Rahman
Journal:  Curr Rheumatol Rep       Date:  2019-01-23       Impact factor: 4.592

Review 4.  Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.

Authors:  Bibiana Bielekova; Michael R Pranzatelli
Journal:  Semin Pediatr Neurol       Date:  2017-08-12       Impact factor: 1.636

5.  A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

Authors:  S Elizabeth Franks; Andrew Getahun; John C Cambier
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

Review 6.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

Review 7.  Anti-cardiac troponin antibodies in clinical human disease: a systematic review.

Authors:  Eduardo M Vilela; Rita Bettencourt-Silva; J Torres da Costa; Ana Raquel Barbosa; Marisa P Silva; Madalena Teixeira; João Primo; Vasco Gama Ribeiro; José Pedro L Nunes
Journal:  Ann Transl Med       Date:  2017-08

8.  B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome.

Authors:  Nikita S Kolhatkar; Nicole E Scharping; Jenna M Sullivan; Holly M Jacobs; Marc A Schwartz; Socheath Khim; Luigi D Notarangelo; Adrian J Thrasher; David J Rawlings; Shaun W Jackson
Journal:  Eur J Immunol       Date:  2015-08-31       Impact factor: 5.532

9.  Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Laura Northrup; Matthew A Christopher; J Daniel Griffin; Francisco Martinez-Becerra; Cory Berkland
Journal:  J Autoimmun       Date:  2018-07-13       Impact factor: 7.094

Review 10.  BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells.

Authors:  Genita Metzler; Nikita S Kolhatkar; David J Rawlings
Journal:  Curr Opin Immunol       Date:  2015-12       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.